Magnetic Resonance Imaging of the Prostate in the PI-RADS Era
- PMID: 31314360
- Bookshelf ID: NBK543790
- DOI: 10.1007/978-3-319-75019-4_11
Magnetic Resonance Imaging of the Prostate in the PI-RADS Era
Excerpt
To understand the current role of prostate MRI for imaging-based targeted prostate biopsy, staging, and active surveillance
To learn how to optimize the multiparametric prostate MR imaging protocol
To illustrate how to use the PI-RADS classification for prostatic lesion assessment
To understand the need of structured reporting in communicating with the urologists
To discuss the most common pitfalls in multiparametric MRI of the prostate
Copyright 2018, The Author(s).
References
-
- Ahmed HU, El-Shater Bosaily A, Brown LC, PROMIS Study Group, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389:815–22. - PubMed
-
- Cash H, Günzel K, Maxeiner A, et al. Men with a negative real-time MRI/ultrasound-fusion guided targeted biopsy but prostate cancer detection on TRUS-guided random biopsy – what are the reasons for targeted biopsy failure? BJU Int. 2016;118:35–43. - PubMed
-
- Cash H, Maxeiner A, Stephan C, et al. The detection of significant prostate cancer is correlated with the prostate imaging reporting and data system (PI-RADS) in MRI/transrectal ultrasound fusion biopsy. Word J Urol. 2016;34:525–32. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous